|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.210 USD | -6.63% |
|
-10.94% | -8.11% |
| 01-08 | MannKind provides business updates and 2026 growth drivers | RE |
| 12-23 | MannKind Says FDA Approves Furoscix Autoinjector Use for Pediatric Patients With Fluid Retention | MT |
EPS & Dividend: MannKind Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.26 | -0.32 | -0.34 | -0.04 | 0.1 | 0.1129 | 0.075 | 0.2371 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.130 | 4.370 | 5.270 | 3.640 | 6.430 | 5.210 | 5.210 | 5.210 |
| Nbr of stocks (in thousands) | 232,601 | 251,256 | 263,196 | 269,575 | 275,778 | 307,070 | 307,070 | - |
| Announcement Date | 25/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | 26/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: MannKind Corporation
| 02/03/2026 | Q4 2025 Earnings Release (Projected) |
| 12/05/2026 | Q1 2026 Earnings Release (Projected) |
| 11/08/2026 | Q2 2026 Earnings Release (Projected) |
| 09/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | 46.16x | - | - | |
| 0.02% | 0.04% | 46.1x | 7.3x | 10.97x | |
| 1.61% | 1.47% | 18.07x | 4.33x | 6.49x | |
| -.--% | -.--% | -27.29x | 91.84x | 59.81x | |
| -.--% | -.--% | -27.72x | 1.26x | 4.82x | |
| -.--% | -.--% | 32.91x | 3.04x | 6.51x | |
| -.--% | -.--% | 18.49x | 3.56x | 4.74x | |
| -.--% | -.--% | -450.14x | 13.12x | 28.71x | |
| -.--% | -.--% | -206.05x | 25.26x | 49.06x | |
| -.--% | -.--% | -13.19x | - | 165.06x | |
| Average | 0.18% | 0.17% | -56.27x | 18.71x | 37.35x | |
| Weighted average by Cap. | 0.3% | 0.28% | -29.03x | 19.61x | 27.30x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition